Surveillance of invasive pneumococcal disease in Germany: surge in PCV13 serotypes and new challenges, 2017 to 2024
BACKGROUND Pneumococcal vaccination has been recommended in Germany for adults aged ≥ 60 years (1998) and children aged < 2 years (2006), resulting in a reduction of pneumococcal disease incidence in vaccinated children and unvaccinated individuals through herd protection. AIM We aimed to investigat...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
European Centre for Disease Prevention and Control
2026-05-01
|
| Серія: | Eurosurveillance |
| Предмети: | |
| Онлайн доступ: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2026.31.21.2500576 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|